Literature DB >> 8046263

Molecular definition of unique species status of Mycobacterium w; a candidate leprosy vaccine strain.

P P Reddi1, A G Amin, P S Khandekar, G P Talwar.   

Abstract

Mycobacterium w, a candidate leprosy vaccine strain, is an atypical cultivable mycobacterium. Based on its growth and metabolic properties, M. w was listed in Runyon Group IV, along with other rapid growers such as M. fortuitum, M. smegmatis, M. chelonae and M. vaccae. However, M. w was not fully identical to any one of these. In the present study, a molecular biology approach was used to define the species identity of M. w in a manner that allows reliable comparison to be made with over 30 known mycobacterial species. A 383-bp region, present at the amino terminus of the conserved mycobacterial 65-kDa gene, has been polymerase chain reaction (PCR) amplified in M. w and DNA sequence was determined. A comparison of the M. w DNA sequence with those of M. tuberculosis, M. avium, M. paratuberculosis and M. fortuitum revealed a species-specific polymorphism, i.e., the presence of nucleotide substitutions unique to M. w. In an alternate approach, a 441-bp region, also a part of the 65-kDa gene, has been PCR amplified in M. w and a Hae III restriction pattern was generated.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8046263

Source DB:  PubMed          Journal:  Int J Lepr Other Mycobact Dis        ISSN: 0148-916X


  10 in total

1.  Design of a non-glycosylated outer domain-derived HIV-1 gp120 immunogen that binds to CD4 and induces neutralizing antibodies.

Authors:  Sanchari Bhattacharyya; Roshan Elizabeth Rajan; Yalla Swarupa; Ujjwal Rathore; Anjali Verma; Ranga Udaykumar; Raghavan Varadarajan
Journal:  J Biol Chem       Date:  2010-06-17       Impact factor: 5.157

2.  A destiny to fulfill.

Authors:  G P Talwar
Journal:  J Biosci       Date:  2005-09       Impact factor: 1.826

3.  Immunogenicity and protective efficacy of "Mycobacterium w" against Mycobacterium tuberculosis in mice immunized with live versus heat-killed M. w by the aerosol or parenteral route.

Authors:  Ankan Gupta; Nishamol Geetha; Jiju Mani; Pramod Upadhyay; V M Katoch; M Natrajan; U D Gupta; Sangeeta Bhaskar
Journal:  Infect Immun       Date:  2008-11-03       Impact factor: 3.441

4.  Mycobacterium indicus pranii supernatant induces apoptotic cell death in mouse peritoneal macrophages in vitro.

Authors:  Rajeev Kumar Pandey; Kunal H Bhatt; Yogesh Dahiya; Ajit Sodhi
Journal:  PLoS One       Date:  2011-02-11       Impact factor: 3.240

5.  Molecular analysis of a leprosy immunotherapeutic bacillus provides insights into Mycobacterium evolution.

Authors:  Niyaz Ahmed; Vikram Saini; Saurabh Raghuvanshi; Jitendra P Khurana; Akhilesh K Tyagi; Anil K Tyagi; Seyed E Hasnain
Journal:  PLoS One       Date:  2007-10-03       Impact factor: 3.240

Review 6.  Development of a potent invigorator of immune responses endowed with both preventive and therapeutic properties.

Authors:  Gursaran P Talwar; Jagdish C Gupta; Abu S Mustafa; Hemanta K Kar; Kiran Katoch; Shreemanta K Parida; Prabhakara P Reddi; Niyaz Ahmed; Vikram Saini; Somesh Gupta
Journal:  Biologics       Date:  2017-05-02

7.  Polyphasic taxonomic analysis establishes Mycobacterium indicus pranii as a distinct species.

Authors:  Vikram Saini; Saurabh Raghuvanshi; Gursaran P Talwar; Niyaz Ahmed; Jitendra P Khurana; Seyed E Hasnain; Akhilesh K Tyagi; Anil K Tyagi
Journal:  PLoS One       Date:  2009-07-16       Impact factor: 3.240

8.  Efficacy of Mycobacterium indicus pranii immunotherapy as an adjunct to chemotherapy for tuberculosis and underlying immune responses in the lung.

Authors:  Ankan Gupta; Farhan J Ahmad; Faiz Ahmad; Umesh D Gupta; Mohan Natarajan; Vishwamohan Katoch; Sangeeta Bhaskar
Journal:  PLoS One       Date:  2012-07-26       Impact factor: 3.240

9.  Mycobacterium indicus pranii (Mw) re-establishes host protective immune response in Leishmania donovani infected macrophages: critical role of IL-12.

Authors:  Anupam Adhikari; Gaurav Gupta; Saikat Majumder; Sayantan Banerjee; Surajit Bhattacharjee; Parna Bhattacharya; Sangeeta Kumari; Subhadra Haldar; Suchandra Bhattacharyya Majumdar; Bhaskar Saha; Subrata Majumdar
Journal:  PLoS One       Date:  2012-07-05       Impact factor: 3.240

10.  Clinico-epidemiological analysis of Post kala-azar dermal leishmaniasis (PKDL) cases in India over last two decades: a hospital based retrospective study.

Authors:  V Ramesh; Himanshu Kaushal; Ashwani Kumar Mishra; Ruchi Singh; Poonam Salotra
Journal:  BMC Public Health       Date:  2015-10-26       Impact factor: 3.295

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.